Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasil Peev

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Transplantation|May 17, 2021
Comparative incidence and outcomes of COVID-19 in kidney or kidney-pancreas transplant recipients versus kidney or kidney-pancreas waitlisted patients: A single-center studyCarlos A Q Santos, Yoona Rhee, Edward F Hollinger, et al.
The Journal of Clinical Investigation|February 13, 2019
Nonimmune cell-derived ICOS ligand functions as a renoprotective αvβ3 integrin-selective antagonistKwi Hye Koh, Yanxia Cao, Steve Mangos, et al.
Nature Medicine|December 13, 2016
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney diseaseEunsil Hahm, Changli Wei, Isabel Fernandez, et al.
The Journal of Clinical Investigation|February 8, 2019
uPAR isoform 2 forms a dimer and induces severe kidney disease in miceChangli Wei, Jing Li, Brian D Adair, et al.
The Journal of Clinical Investigation|September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalSuma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.
Intensive Care Medicine|February 2, 2021
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19Shahzad Shaefi, Samantha K Brenner, Shruti Gupta, et al.
Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Transplantation|May 17, 2021
Comparative incidence and outcomes of COVID-19 in kidney or kidney-pancreas transplant recipients versus kidney or kidney-pancreas waitlisted patients: A single-center studyCarlos A Q Santos, Yoona Rhee, Edward F Hollinger, et al.
The Journal of Clinical Investigation|February 13, 2019
Nonimmune cell-derived ICOS ligand functions as a renoprotective αvβ3 integrin-selective antagonistKwi Hye Koh, Yanxia Cao, Steve Mangos, et al.
Nature Medicine|December 13, 2016
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney diseaseEunsil Hahm, Changli Wei, Isabel Fernandez, et al.
The Journal of Clinical Investigation|February 8, 2019
uPAR isoform 2 forms a dimer and induces severe kidney disease in miceChangli Wei, Jing Li, Brian D Adair, et al.
The Journal of Clinical Investigation|September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalSuma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.
Intensive Care Medicine|February 2, 2021
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19Shahzad Shaefi, Samantha K Brenner, Shruti Gupta, et al.
Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
Pageof 2